首页 › 基金 › PATHWAY CAPITAL MANAGEMENT, LP › HNGE

PATHWAY CAPITAL MANAGEMENT, LP 对 HNGE 的持仓历史

HINGE HEALTH INC · 科技

PATHWAY CAPITAL MANAGEMENT, LP 在 Q3 2026 的 13F 申报中披露持有 HNGE(HINGE HEALTH INC)79,492 股,市值约 US$7.7M,约占其申报组合的 90.08%,在其申报持仓中市值排名第 1 位。 PATHWAY CAPITAL MANAGEMENT, LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)79.49K 股
申报持仓市值$7.73M
组合权重90.08%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

PATHWAY CAPITAL MANAGEMENT, LP 对 HNGE 的持仓演变

PATHWAY CAPITAL MANAGEMENT, LP 于 Q3 2026 首次披露 HNGE 持仓:79,492 股(约 US$7.7M)。

逐季持仓明细

季度股数金额变化
Q3 2026 79.49K $7.73M 新进

关于 HNGE 与 13F 数据

HNGE(HINGE HEALTH INC)属于科技行业。我们追踪的基金中还有 101 只申报持有 HNGE,申报仓位最大的包括:11.2 Capital Management, LLC (US$204.6M), Deer Management Co. LLC (US$158.4M), BIT Capital GmbH (US$119.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 HNGE 的基金

查看 HNGE 的全部基金持有人 →

常见问题

How long has PATHWAY CAPITAL MANAGEMENT, LP held HNGE?

PATHWAY CAPITAL MANAGEMENT, LP has disclosed HNGE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is PATHWAY CAPITAL MANAGEMENT, LP's current position in HNGE?

As of Q3 2026, PATHWAY CAPITAL MANAGEMENT, LP holds 79.49K shares of HNGE (HINGE HEALTH INC), valued at $7.73M, representing 90.08% of its reported portfolio and ranking #1.

Has PATHWAY CAPITAL MANAGEMENT, LP been buying or selling HNGE?

In the latest 13F filing (Q3 2026), PATHWAY CAPITAL MANAGEMENT, LP newly opened its position in HNGE.

Which other funds hold HNGE?

Other major institutional holders of HNGE include 11.2 Capital Management, LLC, Deer Management Co. LLC, BIT Capital GmbH, among 101 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.